OLBA HEALTHCARE HOLDINGS, Inc. (TYO:2689)
Japan · Delayed Price · Currency is JPY 2,054.00
-4.00 (-0.19%)
Jun 4, 2026, 3:30 PM JST
OLBA HEALTHCARE HOLDINGS Income Statement
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 125,999 | 122,702 | 118,564 | 110,472 | 107,959 | 112,976 | |
Revenue Growth (YoY) | 3.58% | 3.49% | 7.32% | 2.33% | -4.44% | 4.71% |
Cost of Revenue | 111,764 | 108,793 | 104,964 | 97,518 | 95,456 | 101,377 |
Gross Profit | 14,235 | 13,909 | 13,600 | 12,954 | 12,503 | 11,599 |
Selling, General & Admin | 12,305 | 11,929 | 11,365 | 10,794 | 10,430 | 10,059 |
Operating Expenses | 12,305 | 11,929 | 11,374 | 10,810 | 10,430 | 10,058 |
Operating Income | 1,931 | 1,980 | 2,226 | 2,144 | 2,073 | 1,541 |
Interest Expense | -54.06 | -37 | -19 | -17 | -20 | -22 |
Interest & Investment Income | 8.32 | 7 | 6 | 2 | 2 | 2 |
Earnings From Equity Investments | - | - | - | - | 26 | -18 |
Currency Exchange Gain (Loss) | 21.17 | 3 | 7 | - | - | - |
Other Non Operating Income (Expenses) | 7.57 | 9 | 23 | 29 | 38 | 39 |
EBT Excluding Unusual Items | 1,914 | 1,962 | 2,243 | 2,158 | 2,119 | 1,542 |
Gain (Loss) on Sale of Investments | -22.83 | -19 | - | - | 12 | -28 |
Gain (Loss) on Sale of Assets | 112.19 | 1 | 1 | 1 | 27 | 1 |
Asset Writedown | -16.57 | -29 | -2 | -2 | -124 | -1 |
Other Unusual Items | 4 | 4 | - | -1 | 102 | -1 |
Pretax Income | 1,989 | 1,919 | 2,242 | 2,156 | 2,136 | 1,513 |
Income Tax Expense | 620.05 | 489 | 742 | 742 | 601 | 524 |
Earnings From Continuing Operations | 1,369 | 1,430 | 1,500 | 1,414 | 1,535 | 989 |
Net Income | 1,369 | 1,430 | 1,500 | 1,414 | 1,535 | 989 |
Net Income to Common | 1,369 | 1,430 | 1,500 | 1,414 | 1,535 | 989 |
Net Income Growth | 3.92% | -4.67% | 6.08% | -7.88% | 55.21% | 203.37% |
Shares Outstanding (Basic) | 6 | 6 | 6 | 6 | 6 | 6 |
Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 | 6 | 6 |
Shares Change (YoY) | 0.06% | -0.64% | -0.98% | -0.87% | -0.15% | 5.77% |
EPS (Basic) | 231.03 | 241.41 | 251.62 | 234.86 | 252.75 | 162.60 |
EPS (Diluted) | 231.03 | 241.41 | 251.62 | 234.86 | 252.75 | 162.60 |
EPS Growth | 3.84% | -4.06% | 7.13% | -7.08% | 55.44% | 186.81% |
Free Cash Flow | - | 181 | 1,733 | -820 | 2,123 | 2,747 |
Free Cash Flow Per Share | - | 30.56 | 290.70 | -136.20 | 349.57 | 451.63 |
Dividend Per Share | 80.000 | 80.000 | 80.000 | 70.000 | 60.000 | 45.000 |
Dividend Growth | - | - | 14.29% | 16.67% | 33.33% | 12.50% |
Gross Margin | - | 11.34% | 11.47% | 11.73% | 11.58% | 10.27% |
Operating Margin | 1.53% | 1.61% | 1.88% | 1.94% | 1.92% | 1.36% |
Profit Margin | 1.09% | 1.17% | 1.26% | 1.28% | 1.42% | 0.88% |
Free Cash Flow Margin | - | 0.15% | 1.46% | -0.74% | 1.97% | 2.43% |
EBITDA | 2,619 | 2,615 | 2,790 | 2,653 | 2,476 | 1,943 |
EBITDA Margin | - | 2.13% | 2.35% | 2.40% | 2.29% | 1.72% |
D&A For EBITDA | 688.25 | 635 | 564 | 509 | 403 | 402 |
EBIT | 1,931 | 1,980 | 2,226 | 2,144 | 2,073 | 1,541 |
EBIT Margin | - | 1.61% | 1.88% | 1.94% | 1.92% | 1.36% |
Effective Tax Rate | - | 25.48% | 33.09% | 34.42% | 28.14% | 34.63% |